guidance.fyi
Company, ticker, metric, guidance, or anything said
VerifiedNumbers checked and claims independently audited

Q1 FY27 concall · earnings callIndia Pesticides Limited

A challenging quarter marked by subdued domestic demand from erratic monsoon, offset by strategic progress on new manufacturing blocks and a key EU approval for fungicide exports.

Cautious tone4-minute briefPublished 8 days after the call

Numbers
MetricThis quarterChangeFive-quarter trend
Consolidated Revenue₹256 Cr-9.2%
EBITDA₹39 Cr—
EBITDA Margin15.4%—
PAT₹23 Cr—
Export Revenue₹89 Cr—
Financials

From filed quarterly results. YoY and QoQ compare each metric on the same accounting basis.

QuarterRevenueNet profit (PAT)Basic EPS
Q3 FY25₹172.22 Cr+14.3% YoY-24.7% QoQ₹16.07 Cr-33% YoY-38% QoQ₹1.40-33% YoY-37.8% QoQ
Q2 FY25₹228.78 Cr+13.3% YoY+3.8% QoQ₹25.91 Cr+32.8% YoY+33% QoQ₹2.25+32.4% YoY+33.1% QoQ
Q1 FY25₹220.36 Cr+9.4% YoY+74.4% QoQ₹19.48 Cr+26.1% YoY+1737.7% QoQ₹1.69+25.2% YoY+1777.8% QoQ
Q4 FY24₹126.32 Cr-36.3% YoY-16.2% QoQ₹1.06 Cr-96.5% YoY-95.6% QoQ₹0.09-96.6% YoY-95.7% QoQ
Q3 FY24₹150.68 Cr-30.8% YoY-25.4% QoQ₹23.99 Cr-31.1% YoY+23% QoQ₹2.09-30.8% YoY+22.9% QoQ
TL;DR
  • Revenue declined 9.2% YoY to INR 256 crores due to softer domestic demand, especially for herbicide Pretilachlor.
  • EBITDA margin was 15.4%, impacted by lower volumes, higher employee/fuel costs, and one-off expenses.
  • Exports contributed 35% of revenue and grew slightly YoY.
  • Received Technical Equivalence approval from the EU for a fungicide, expected to add INR 30-40 crores revenue.
  • Hamirpur facility expansion is on track, with 2 of 10 blocks operational, targeting INR 50-60 crores revenue this year and INR 1000 crores in 4 years.
  • Developing a new fungicide currently imported from China, targeting a 2000-ton capacity from existing Sandila plant.
Said on the call

“We are trying to improve our operational efficiency and trying to compete with Chinese imports and that is where our R&D team is working regularly to optimize further the process conditions.”

D. K. Jain, CEO
From the Q&A
TopicWhat management said
Margin PressureCFO explained lower operating margin due to one-time write-off of export receivables (INR 2.5 Cr) and higher job work charges (INR 6 Cr) incurred in anticipation of higher sales that didn't materialize.
New Product PipelineCEO detailed a new fungicide, currently imported from China (~4000-5000 tons), which IPL will produce domestically targeting 2000 tons capacity at ~INR 500-600/kg, aiming to reduce dependence on single molecules.
Hamirpur Facility OutlookManagement expects INR 50-60 crores revenue from Hamirpur this year, with a long-term potential of INR 1000 crores in 3-4 years from 8-10 blocks, requiring annual capex of INR 80-100 crores.
Volume vs PriceCFO clarified the revenue decline was driven by a 13% volume drop, partially offset by a 4% price increase.
FY27 GuidanceCFO stated expecting lower single-digit revenue growth for the full year, with Q3 and Q4 expected to be better.
Guidance
  • Expect lower single-digit revenue growth for FY27.
  • Target sustainable EBITDA margin of 15-18%.
  • Expect revenue of INR 50-60 crores from Hamirpur facility in FY27.
  • Anticipate additional INR 30-40 crores revenue from the EU-approved fungicide molecule.
  • Plan annual capex of INR 80-100 crores at Hamirpur and INR 25-30 crores at Sandila.
  • Inventory days expected to reduce from ~200 days to ~170 days by Q3.
Source
Same sector

Others in Chemicals

All Chemicals →
  • Prasol Chemicals LimitedQ1 FY27Positive tone

    Q1 FY27 was exceptionally strong on inventory gains from West Asia-led acetone price rises, while underlying mid-single-digit volume growth remained healthy and management guided for INR1,550 crores to INR1,650 crores revenue in FY27 with normalization of margins ahead.

    Revenue from operations - Q1 FY27
    ₹433.6 Cra growth of 35.7% YoY
    Gross margin - Q1 FY27
    37.9%compared to 30% in Q1 FY26
    PRASOLCHEMChemicalsVerified brief5 guidance items
  • Solar Industries India LimitedQ1 FY27Positive tone

    Solar Industries agreed to acquire South Africa's Omnia Holdings for cash funded by debt and internal accruals to build an integrated global explosives and blasting solutions platform with backward integration into ammonium nitrate.

    Solar projected current year revenue
    ₹14,000 Cr
    Solar projected FY28 revenue
    ₹16,500 Cr
    SOLARINDSChemicalsVerified brief4 guidance items
  • Indo Borax & Chemicals LimitedQ1 FY27Positive tone

    Q1 FY27 delivered 31.34% revenue growth and 59.31% profit growth from better utilization and realizations while Indo Borax moved to acquire 64.26% of Kronox Lab Sciences.

    Operating revenue
    ₹70.36 Cr+31.34% increase against ₹53.57 Cr in Q1 FY 26
    EBITDA
    ₹19.8 Crup by 62.16% vs ₹12.21 Cr in Q1 FY 26
    INDOBORAXChemicalsVerified brief5 guidance items
  • Stallion India started FY27 with strong profit growth and is focusing on executing key expansion projects, including its high-purity helium and R32 manufacturing facilities, to drive future growth.

    Total Revenue
    124.68 crores12.78%
    EBITDA
    25.27 crore75.85%
    STALLIONChemicalsVerified brief4 guidance items
  • Ester Industries LimitedQ1 FY27Positive tone

    The quarter was driven by a strong rebound in the BOPET film business due to improved industry pricing and capacity utilization, leading to a significant turnaround in consolidated profitability.

    Consolidated Total Income
    ₹441.9 Cr27.4%
    Consolidated EBITDA
    ₹58.9 Cr103.4%
    ESTERChemicalsVerified brief4 guidance items